Uploaded May 2018 | Updated September 2026, 9 minutes ago

---

Akash Kansagra, MD, Washington University neurointerventional surgeon at Barnes-Jewish Hospital, talks about the latest clinical trials and advances in technology for treating stroke. The DEFUSE 3 and DAWN trials have expanded the time window for effectively treating stroke patients from just 6 hours after symptoms start to 24 hours. This results in better outcomes and can help patients live a normal life after having a stroke.

To learn more about stroke research and clinical trials at Barnes-Jewish Hospital, visit: barnesjewish.org/Medical-Services/Neurology-Neurosurgery/Stroke-Center/Stroke-Research-and-Clinical-Trials.

Subscribe to the Barnes-Jewish Hospital YouTube Channel: youtube.com/user/BarnesJewishHospital

Connect with Barnes-Jewish Hospital:
- Facebook: facebook.com/barnesjewishhospital
- Twitter: twitter.com/Barnesjewish